Nektar TherapeuticsNKTRNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-9.4%
5Y CAGR-8.1%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-9.4%/yr
vs +3.2%/yr prior
5Y CAGR
-8.1%/yr
Consistent
Acceleration
-12.6pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $68.67M | -10.5% |
| 2024 | $76.75M | -0.9% |
| 2023 | $77.42M | -16.2% |
| 2022 | $92.33M | -24.8% |
| 2021 | $122.84M | +17.3% |
| 2020 | $104.68M | +6.0% |
| 2019 | $98.71M | +21.2% |
| 2018 | $81.44M | +55.5% |
| 2017 | $52.36M | +18.3% |
| 2016 | $44.27M | - |